17 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
in inflation, along with the uncertainties surrounding any resurgence of COVID-19, geopolitical developments and global supply chain disruptions, have … to regulate pharmaceutical benefit managers (“PBMs”) and other members of the healthcare and pharmaceutical supply chain, an important decision that may
6-K
EX-99
BLRX
Bioline Rx Ltd
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
-readiness activities. We recently completed hiring an experienced sales force, and have substantially advanced supply chain, market access and medical
424B5
aqwh3x2ugk
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
9oep3oqr9j4ah0w5i2
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
iw13 0xl1d4xm
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
hfja1z4rur1tv63q
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
3xamyy1k691
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
2is67x 1zwmusa
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
a3dqlypv9ldug
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
tl67w6k369hb8e1
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B5
a84hmmy9alloacqr
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
irvqb5 wqq7u0o
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
uvo9f6
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
- Prev
- 1
- Next